title: Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension.
abstract: BACKGROUND
  Hyponatremia is associated with decompensated heart failure and poor prognosis in patients with left ventricular systolic dysfunction.
  
  
  OBJECTIVE
  We sought to determine if hyponatremia is associated with right heart failure and worse prognosis in patients with pulmonary arterial hypertension (PAH).
  
  
  METHODS
  We prospectively followed 40 patients with PAH and examined the relationship between serum sodium and right heart function as well as survival.
  
  
  RESULTS
  Subjects with hyponatremia (Na < or = 136 mEq/L) were more symptomatic (11/13 World Health Organization [WHO] class III/IV vs. 12/27 WHO class III/IV; P = 0.02), had more peripheral edema (69 vs. 26%; P = 0.009), and had higher hospitalization rates (85 vs. 41%; P = 0.009) than normonatremic subjects. Hyponatremic subjects had higher right atrial pressure (14 +/- 6 vs. 9 +/- 3 mm Hg; P < 0.001), lower stroke volume index (21 +/- 7 vs. 32 +/- 10 ml/m(2); P < 0.01), larger right ventricular:left ventricular area ratio (1.8 +/- 0.4 vs. 1.3 +/- 0.4; P < 0.001), and lower tricuspid annular plane systolic excursion (1.4 +/- 0.3 vs. 2.0 +/- 0.6 cm; P = 0.001), despite similar mean pulmonary artery pressure (49 +/- 10 vs. 47 +/- 12 mm Hg; P = 0.60). The 1- and 2-year survival estimates were 93% (95% confidence interval [CI], 73-98%) and 85% (95% CI, 65-94%), and 38% (95% CI, 14-63%) and 15% (95% CI, 2-39%) for normonatremic and hyponatremic subjects, respectively (log-rank chi(2) = 25.19, P < 0.001). The unadjusted risk of death (hazard ratio) in hyponatremic compared with normonatremic subjects was 10.16 (95% CI, 3.42-30.10, P < 0.001). Hyponatremia predicted outcome after adjusting for WHO class, diuretic use, as well as right atrial pressure and cardiac index.
  
  
  CONCLUSIONS
  Hyponatremia is strongly associated with right heart failure and poor survival in PAH.
authors: Cardiovascular Division, Heart Failure/Transplant Program, University of Pennsylvania School of Medicine, 3400 Spruce Street, 6 Penn Tower, Philadelphia, PA 19104, USA. paul.forfia@uphs.upenn.edu
authors: Paul R
authors: PR
authors: Forfia
authors: Stephen C
authors: SC
authors: Mathai
authors: Micah R
authors: MR
authors: Fisher
authors: Traci
authors: T
authors: Housten-Harris
authors: Anna R
authors: AR
authors: Hemnes
authors: Hunter C
authors: HC
authors: Champion
authors: Reda E
authors: RE
authors: Girgis
authors: Paul M
authors: PM
authors: Hassoun
mesh_terms: D016022:Case-Control Studies; D005260:Female; D006333:Heart Failure / Q000097:blood* / Q000175:diagnosis / Q000209:etiology / Q000401:mortality; D006801:Humans; D006955:Hypernatremia / Q000097:blood* / Q000209:etiology / Q000401:mortality; D006976:Hypertension, Pulmonary / Q000150:complications / Q000175:diagnosis* / Q000401:mortality*; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D016016:Proportional Hazards Models; D011446:Prospective Studies; D012720:Severity of Illness Index; D015996:Survival Rate